CASP3 and neoplasm: The BACH1 targeting reduces the expression of tumor-associated metabolites, glycolytic enzymes, and metastasis-related proteins, while mitochondrial targeting induces membrane depolarization, ROS overproduction, and activation of caspase-3 and caspase-9.